openPR Logo
Press release

Antibacterial Drugs Market: Key Trends, Industry Opportunities And Projections for Upcoming Years

06-21-2017 03:44 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Antibacterial Drugs Market: Key Trends, Industry

An antibacterial drug is referred to as an antimicrobial agent interfering with the growth and reproduction of bacteria that cause numerous mild to severe infections in humans and animals. Antibacterial drugs either kill or inhibit their growth. These agents possess bactericidal activity which target various parts of bacterial physiology such as protein synthesis, cell wall synthesis, nucleic acid synthesis and permeability of cell membrane, and therefore help in treating infections. Antibacterial drugs are being in use since the discovery of the first antibacterial in the form of penicillin in 1928, and presently a wide range of antibacterials in several formulations are commercially available and used for the treatment of various indications like pneumonia, tuberculosis, tetanus, diphtheria, diarrhea, legionellosis and other diseases.

Read the Comprehensive Overview of Antibacterial Drugs Market: http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

The global antibacterial drugs market has been categorized into eight segments based on their class which include: aminoglycosides, β-lactams, tetracyclines, sulfonamides, quinolones/ fluoroquinolones, macrolides, phenicols, and miscellaneous antibacterials. In 2014, β-lactams occupied the leading position with a share of 57.7% of the global antibacterial drugs market followed by the quinolones. However, these drug classes are expected to witness a decline in their market share during the forecast period due to scheduled patent expiry of key branded formulations, coupled with growing number of drug resistant bacterial strains and increasing influx of generic drugs. Hence, on account of the factors mentioned above, the global antibacterial drugs market is expected to witness slow growth during the forecast period 2015 to 2023. However, the miscellaneous antibacterials segment is expected to grow with the highest CAGR accompanied with growing demand for therapies against bacterial infections and rising geriatric populations are some of the factors that are anticipated to maintain the growth of the antibacterial drugs market. Additionally, expected commercialization of various antibacterial agents that are currently in developmental stages, such as solithromycin (Cempra, Inc.), VivaGel (SPL7013) (Starpharma Holdings Limited), surotomycin (Merck & Co.) MK-3415A (Merck & Co.) during the forecast period is also expected to profound impact on growth of this market.

Asia-Pacific held the largest share of the revenue generated by the global antibacterial drugs market in 2014. This region is also expected to experience the highest growth rate during the forecast period 2015 to 2023. The major factors responsible for this region to hold leadership in this market in 2014 include presence of large number of generic manufacturers and active pharmaceutical ingredient (API) manufacturers in Asian countries, growing incidences of bacterial infections such as MRSA (methicillin resistant Staphylococcus aureus) and tuberculosis and increasing purchasing power of the domestic population. Moreover, developing health care infrastructure, presence of a large population base and growing geriatric population which is more prone to diseases would consequently increase the uptake of antibacterial drugs in Asia. North America held the second largest revenue share followed by Europe in the antibacterial drugs market in 2014. Market maturity, shortened product lifecycle, stringent regulatory requirements and generic infiltration are some of the factors that accounted for slow growth of this market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567

AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Allergen plc, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi are the major players engaged in the development, production and marketing of various antibacterial drugs. These players have worldwide presence in the pharmaceutical industry and are involved in constant competition with each other. Pfizer, Inc. was observed to be the most promising and leading player in the Antibacterial drugs market. Major customers for their antibacterial drugs include hospitals, private clinics, physicians and patients.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibacterial Drugs Market: Key Trends, Industry Opportunities And Projections for Upcoming Years here

News-ID: 590146 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Antibacterial

Antibacterial Masks Market 2021 | Detailed Report
Global Antibacterial Masks Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures)
Global Antibacterial Drugs Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Antibacterial Drugs Market will expand at a CAGR value of 4.2% to reach USD 41.5 billion by 2026. The increasing demand for efficient and inexpensive antibacterial drugs, and also the increasing number of multi-drug resistant bacterial strains, are some of the primary factors driving the market growth. Browse 117 Market Data Tables and 117 Figures spread through
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an
Antibacterial Filter Market - Key Development by 2027
Antibacterial Filter Market 2020 report focuses on the major drivers and restraints for the Global key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The recent research report on the global Antibacterial Filter market presents the latest industry data and future trends, allowing you to recognize the products and end users driving Revenue growth and profitability of the market. The report
Global Antibacterial Drugs Market Research Report
This report studies the global Antibacterial Drugs market status and forecast, categorizes the global Antibacterial Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bayer AG Pfizer Inc. Sanofi GlaxoSmithKline Plc. (GSK) Merck & Co., Inc. AstraZeneca Johnson and Johnson Bristol
Global Antibacterial Drugs Market: Regional Overview
The global antibacterial drugs market features a fairly competitive landscape and leading players include Allergan, Plc., Novartis AG, Bristol Myers Squibb Company, Johnson and Johnson, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline Plc. (GSK), Sanofi, Pfizer Inc., Bayer AG, notes Transparency Market Research (TMR). Over the years, the competition in the market is expected to intensify. A number of prominent players are focusing on entering into strategic collaborations and mulling